Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

The three “Ws” of early breast cancer management

Adjuvant endocrine therapy: Who needs more than 5 years, which regimen, and what duration beyond 5 years?

Date

10 Sep 2022

Session

The three “Ws” of early breast cancer management

Topics

Endocrine Therapy

Tumour Site

Breast Cancer

Presenters

Evandro de Azambuja

Authors

E. de Azambuja

Author affiliations

Medical Oncology Department, Institute Jules Bordet, 1000 - Brussels/BE

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

10 Sep 2022

Gene expression profiling and chemotherapy: Who to test, which test, and when

Presenter: Aleix Prat

Session: The three “Ws” of early breast cancer management

Resources:

Slides

Webcast

10 Sep 2022

Neo-adjuvant therapy in luminal breast cancer: Who to treat, which regimen, and what duration?

Presenter: Nadia Harbeck

Session: The three “Ws” of early breast cancer management

Resources:

Slides

Webcast

10 Sep 2022

Discussion

Presenter: All Speakers

Session: The three “Ws” of early breast cancer management

Resources:

Webcast